Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China; Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
Department of Urology, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China.
J Urol. 2016 Aug;196(2):335-42. doi: 10.1016/j.juro.2016.02.2971. Epub 2016 Mar 10.
Vascular mimicry is a type of tumor cell plasticity. The aim of this study was to determine the prognostic value of vascular mimicry in patients with clear cell renal cell carcinoma.
We performed a retrospective cohort study in 387 patients with clear cell renal cell carcinoma who underwent radical nephrectomy at Zhongshan Hospital, Fudan University between 2008 and 2009. Pathological features, baseline patient characteristics and followup data were recorded. Vascular mimicry in clear cell renal cell carcinoma tissue was identified by CD31-periodic acid-Schiff double staining. Univariate and multivariate Cox regression models were used to analyze the impact of prognostic factors on recurrence-free survival. The concordance index and the Akaike information criterion were used to assess the predictive accuracy and sufficiency of different models.
Positive vascular mimicry staining occurred in 25 of 387 clear cell renal cell carcinoma cases (6.5%) and it was associated with an increased risk of recurrence (log-rank p <0.001). Incorporating vascular mimicry into pT stage, Fuhrman grade and Leibovich score helped refine individual risk stratification. Moreover, vascular mimicry was identified as an independent prognostic factor (p = 0.001). It was entered into a nomogram together with pT stage, Fuhrman grade, tumor size and necrosis. In the primary cohort the Harrell concordance index for the established nomogram to predict recurrence-free survival was slightly higher than that of the Leibovich model (0.850 vs. 0.823), which failed to reach statistical significance (p = 0.158).
Vascular mimicry could be a potential prognosticator for recurrence-free survival in patients with clear cell renal cell carcinoma after radical nephrectomy. Further external validation and functional analysis should be pursued to assess its potential prognostic and therapeutic values for clear cell renal cell carcinoma.
血管拟态是肿瘤细胞可塑性的一种类型。本研究旨在确定血管拟态在透明细胞肾细胞癌患者中的预后价值。
我们对 2008 年至 2009 年在复旦大学中山医院接受根治性肾切除术的 387 例透明细胞肾细胞癌患者进行了回顾性队列研究。记录了病理特征、基线患者特征和随访数据。通过 CD31-过碘酸雪夫双重染色鉴定透明细胞肾细胞癌组织中的血管拟态。采用单因素和多因素 Cox 回归模型分析预后因素对无复发生存的影响。采用一致性指数和赤池信息量准则评估不同模型的预测准确性和充分性。
387 例透明细胞肾细胞癌中,有 25 例(6.5%)出现阳性血管拟态染色,且与复发风险增加相关(log-rank p<0.001)。将血管拟态纳入 pT 分期、Fuhrman 分级和 Leibovich 评分有助于细化个体风险分层。此外,血管拟态被确定为独立的预后因素(p=0.001)。它与 pT 分期、Fuhrman 分级、肿瘤大小和坏死一起被纳入一个列线图。在原始队列中,该列线图预测无复发生存的 Harrell 一致性指数略高于 Leibovich 模型(0.850 比 0.823),但无统计学意义(p=0.158)。
血管拟态可能是根治性肾切除术后透明细胞肾细胞癌患者无复发生存的潜在预后指标。应进一步进行外部验证和功能分析,以评估其对透明细胞肾细胞癌的潜在预后和治疗价值。